As cases of the coronavirus continue to surge on a global scale, some of the nation’s most prominent people have begun to double up on masks — a move that researchers say is increasingly being backed up by data.

So far, at least 22.1 million doses of coronavirus vaccines have been distributed and nearly 6.7 million have made their way into patients' arms.

6.7 million Americans have now received a single dose, while 22 million doses have been distributed to hospitals and pharmacies.

As the slow and steady coronavirus vaccine rollout continues in the United States, the massive effort is still lacking in the “four D’s” needed for success.

Friday January 8, 2021 12:00-12:30 ET As the pandemic continues to surge, join Johns Hopkins experts at noon on Friday for a webcast briefing on the latest COVID-19 data and trends.

As the United States marked another grim milestone with more than 4,000 COVID-19 deaths reported in a single day, federal disease trackers said research suggests that people without symptoms transmit more than half of all cases of the novel coronavirus.

The mutant variant of the novel coronavirus first seen in Britain is likely to be present in much of the United States.

Johns Hopkins International Vaccine Access Center Executive Director Dr. William Moss discusses issues with the rollout of COVID-19 vaccines in the United States.

Vaccines are finally starting to roll out, but the virus is spreading faster than ever — and killing thousands of Americans daily. 

The vaccine is allocated according to the number of adults in each state, which doesn’t correlate to the number of high-risk people there.

Friday December 18, 2020 12:00-1:00 ET As the pandemic surges to dangerous, record-breaking levels, we are launching the first in a series of bi-weekly webcast briefings on the CRC this coming Friday at noon. The series will provide timely, accessible updates on the state of the pandemic and public health responses, and will offer opportunities for live Q&A with leading experts from the Johns Hopkins Coronavirus Resource Center.

The Moderna coronavirus vaccine was recommended for emergency authorization by an FDA panel, following the FDA approval of the Pfizer vaccine last week